Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome

J Invest Dermatol. 2022 Sep;142(9):2534-2537.e1. doi: 10.1016/j.jid.2022.02.004. Epub 2022 Feb 17.

Authors

Jessica N Hatton¹, Michael R Sargen², Megan N Frone², Kelvin C de Andrade², Sharon A Savage², Payal P Khincha²

Affiliations

¹ Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, USA. Electronic address: Jessica.hatton@nih.gov.
² Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, Maryland, USA.

No abstract available

Publication types

Research Support, N.I.H., Intramural

MeSH terms

Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Incidence
Li-Fraumeni Syndrome* / epidemiology
Li-Fraumeni Syndrome* / genetics
Skin Neoplasms* / epidemiology
Skin Neoplasms* / genetics
Tumor Suppressor Protein p53 / genetics

Substances

Tumor Suppressor Protein p53

Grants and funding